Get the Stockscreener App
79.10
0.84%
-0.75
Henry Schein Inc stock is traded at $79.10, with a volume of 333.59K.
It is down -0.84% in the last 24 hours and up +10.48% over the past month.
See More
Previous Close:
$79.85
Open:
$79.71
24h Volume:
333.59K
Relative Volume:
0.22
Market Cap:
$9.32B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
32.42
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-1.03%
1M Performance:
+10.48%
6M Performance:
+20.39%
1Y Performance:
+5.21%
1-Day Range:
$78.68
$80.10
1-Week Range:
$78.57
$82.49
52-Week Range:
$63.67
$82.63
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
79.11 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
600.10 | 77.79B | 330.19B | 2.54B | 4.31B | 19.31 |
|
COR
Cencora Inc
|
248.31 | 47.73B | 293.96B | 1.51B | 3.00B | 7.51 |
|
CAH
Cardinal Health Inc
|
127.75 | 30.95B | 222.16B | 1.31B | -486.00M | 5.36 |
|
PDCO
Patterson Companies Inc
|
31.02 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein, Inc. (NASDAQ:HSIC) Receives $80.10 Average Target Price from Analysts - MarketBeat
Barrington Research Comments on Henry Schein FY2026 Earnings - MarketBeat
NAW Dirk Van Dongen Lifetime Achievement Award given to Stanley M. Bergman - Fire & Safety Journal Americas
Private Management Group Inc. Buys 18,882 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Acquires Acentus to Expand Homecare Solutions - The Healthcare Technology Report.
Henry Schein CEO honored - HME News
Henry Schein Medical Honors Women Trailblazers in Athletic Training on National Girls and Women in Sports Day 2025 - Business Wire
Henry Schein, Inc. (NASDAQ:HSIC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
U.S. private equity firm KKR becomes largest non-index fund shareholder in Henry Schein - Oral Health
SPP Dental Partners & Henry Schein Host Exclusive Dental Marketing Summit in Del Mar, CA on April 25, 2025 - EIN News
Dentsply Sirona, Colgate, Henry Schein among 500 U.S. companies recognized by Newsweek for sustainability - Oral Health
Velir Reimagines Henry Schein One's Digital Experience with Cutting-Edge Optimizely Implementation - Morningstar
UBS Adjusts Price Target on Henry Schein to $83 From $73, Maintains Neutral Rating - Marketscreener.com
Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Pacer Advisors Inc. - Defense World
Cibc World Market Inc. Purchases 9,954 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Barrington Research Cuts Earnings Estimates for Henry Schein - MarketBeat
Henry Schein (NASDAQ:HSIC) Trading 6.2% HigherHere's What Happened - MarketBeat
Henry Schein Completes Acquisition of Acentus - Zenopa
Henry Schein (NASDAQ:HSIC) Price Target Raised to $90.00 at Barrington Research - MarketBeat
Leerink Partnrs Reduces Earnings Estimates for Henry Schein - MarketBeat
KBC Group NV Has $10.25 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Everett Harris & Co. CA Buys 8,015 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
KKR builds stake in Henry Schein, reaches deal to add board seats - MSN
Henry Schein (NASDAQ:HSIC) Updates Q4 2024 Earnings Guidance - MarketBeat
Swedbank AB Has $50.40 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein (NASDAQ:HSIC) Releases FY 2024 Earnings Guidance - MarketBeat
Barrington Research Raises Henry Schein (NASDAQ:HSIC) Price Target to $90.00 - Defense World
Henry Schein Announces Strategic Partnership Agreement with KKR: Board Changes and Financial Results - Defense World
Barrington Research Estimates Henry Schein Q1 Earnings - Defense World
Henry Schein Gains $250M Investment From KKR, Strengthens Growth Strategy - Dentistry Today
Mizuho raises Henry Schein stock target to $78, keeps neutral stance - MSN
Clear Aligners Market on Track for Strong Growth by 2031 | Henry Schein, Inc., TP Orthodontics, Inc., DynaFlex. - openPR
Kirkland Advises KKR on Strategic Investment in Henry Schein - Legal Desire News Network
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal - MSN
What Analysts Are Saying About Henry Schein Stock - Benzinga
Henry Schein announces KKR investment, prelim. Q4 sales (update) - MSN
Barrington Research Adjusts Henry Schein Price Target to $90 From $82 -January 30, 2025 at 09:11 am EST - Marketscreener.com
Jefferies Adjusts Henry Schein Price Target to $87 From $80 -January 30, 2025 at 09:10 am EST - Marketscreener.com
American KKR acquired 12% stake in Henry Schein medical company - AK&M News
With its stake in Henry Schein, KKR pushes shared ownership of public companies - ImpactAlpha
Root Canal Files Market Growth in Future Scope 2025-2032 | Henry - openPR
Henry Schein gets $250 million investment from private equity firm KKR - Newsday
KKR to acquire 12% stake in Henry Schein - MSN
Henry Schein gains as KKR reportedly builds stake - MSN
Henry Schein Partners with KKR for Strategic Growth - TipRanks
KKR Builds Stake in Henry Schein With $250M Investment - USA Herald
KKR Plugs $250M Into Healthcare Biz Henry Schein - Law360
Henry Schein, Inc. announced that it expects to receive $250 million in funding from KKR & Co. Inc. - Marketscreener.com
Henry Schein Announces Strategic Investment by KKR - citybiz
KKR builds 12% stake, takes board seats in medical supply company Henry Schein - Axios
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
1.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):